Rheumatoid arthritis vaccine (Immune Response BioPharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRheumatoid arthritis vaccine (Immune Response BioPharma)
Drug Alias Name类风湿性关节炎疫苗 - Immune Response BioPharmaRavaxZyvac-RAIR-703IR-501 +[9] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesImmune Response Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmune Response Biopharma Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A